Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02985736Phase 4Completed
Phase 4, open-label, single-arm trial of desoximetasone in psoriasis, sponsored by Psoriasis Treatment Center of Central New Jersey. Primary endpoint: Investigator Global Assessment (Scalp Only) at 16 weeks. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02985736.